| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 08/20/2009 | US20090209524 Novel Compounds |
| 08/20/2009 | US20090209519 Pyrimidine compound and pests controlling composition containing the same |
| 08/20/2009 | US20090209518 Pyrimidine compound and pests controlling composition containing the same |
| 08/20/2009 | US20090209451 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes |
| 08/20/2009 | US20090206731 Rigid Amines |
| 08/20/2009 | DE102008009609A1 Substituierte 4-(Indol-3-yl)chinazoline und deren Verwendung und Herstellung Substituted 4- (indol-3-yl) quinazolines and their use and production |
| 08/20/2009 | CA2715839A1 Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors |
| 08/20/2009 | CA2715559A1 Hepatitis c virus inhibitors |
| 08/20/2009 | CA2715550A1 Conformationally restricted biphenyl derivatives for use as hepatitis c virus inhibitors |
| 08/20/2009 | CA2715400A1 Heterocyclic derivatives as hepatitis c virus inhibitors |
| 08/20/2009 | CA2715367A1 Hepatitis c virus inhibitors |
| 08/20/2009 | CA2714532A1 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| 08/20/2009 | CA2714087A1 Inhibitors of checkpoint kinases |
| 08/20/2009 | CA2713404A1 Pyrimidylmethyl sulfonamide compounds |
| 08/20/2009 | CA2713378A1 3-alkyl-piperazine derivatives and uses thereof |
| 08/20/2009 | CA2713112A1 Pharmaceutical compositions comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide |
| 08/19/2009 | EP2090579A1 Substituted heteroarylamide diazepinopyrimidone derivatives |
| 08/19/2009 | EP2090575A1 Processes and intermediates for the preparation of N4-phenyl-quinazoline-4-amine derivatives |
| 08/19/2009 | EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 08/19/2009 | EP2090306A1 Pharmaceutical compositions comprising N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| 08/19/2009 | EP2089384A2 2-(piperidin-4-yl)-4-phenoxy-or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors |
| 08/19/2009 | EP2089383A1 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| 08/19/2009 | EP2089382A1 Substituted diazepan compounds as orexin receptor antagonists |
| 08/19/2009 | EP2089369A2 2,4 -pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 08/19/2009 | EP2035394B1 2-pyrazinecarboxamide derivatives |
| 08/19/2009 | EP1838304B1 Heterocyclic aspartyl protease inhibitors |
| 08/19/2009 | EP1590334B1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta |
| 08/19/2009 | EP1470114B1 Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones |
| 08/19/2009 | EP1119356B1 Radiolabeled neurokinin-1 receptor antagonists |
| 08/19/2009 | CN101511825A Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (GSK3) |
| 08/19/2009 | CN101511824A Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (GSK3) |
| 08/19/2009 | CN101511823A Multifunctional bioactive compounds |
| 08/19/2009 | CN101511822A Modulators of chemokine receptor activity, crystalline forms and process |
| 08/19/2009 | CN101511821A Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors |
| 08/19/2009 | CN101511812A Pyrazole derivatives as cytochrome P450 inhibitors |
| 08/19/2009 | CN101511800A Triazolyl phenyl benzenesulfonamides |
| 08/19/2009 | CN101511797A Benzimidazole modulators of VR1 |
| 08/19/2009 | CN101511359A Benzotriazole kinase modulators |
| 08/19/2009 | CN100528867C Triazine radical amido diphenyl ethylene fluorescent bleaches |
| 08/19/2009 | CN100528866C Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
| 08/19/2009 | CN100528865C Imidazolo-5-yl-anilinopyrimidines as agents for the inhibition of cell proliferation |
| 08/19/2009 | CN100528848C Maleimide resin with cyanurate core |
| 08/19/2009 | CN100528846C Amine compounds and use thereof |
| 08/18/2009 | US7576245 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups; increasing the fluorous nature of an organic compound; 4-(1H,1H,2H,2H-Perfluorodecyl)benzenesulfonamide; N-[4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyloxy]succinimide |
| 08/18/2009 | US7576209 Breast, prostate and ovarian cancer; such as 1-[4-(9-phenyl-3-pyrimidin-2-yl[1,2,4]triazolo[3,4-f]-1,6-naphthyridin-8-yl)phenyl]cyclobutanamine; serine/threonine kinase (Akt) suppression |
| 08/18/2009 | US7576198 A hydroxy compound containing substituted orpyridine, pyrazine, pyrimidine, oxazole, thiadiazole, quinoline, isoquinoline etc. as anti HIV agent, for treating AIDS |
| 08/18/2009 | US7576120 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them |
| 08/18/2009 | US7576115 1-methyl,3-alkaminothiocarbonylhydrazonomethyl,4-hydroxy,5-phenyl pyrazole; low-molecular-weight, nonpeptidic thrombopoietin receptor agonist; oral administration; bioavailability; blood disorders; platelet-increasing agents; angiogenesis; arteriosclerosis; blood/stem cell stimulant; thrombocytopenia |
| 08/18/2009 | US7576114 6-(4-Bromo-2-chloro-phenylamino)-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide; anticarcinogenic, antiproliferative, and antiinflammatory agents; mitogen-activated protein kinase inhibitors |
| 08/18/2009 | US7576104 4-(Aminomethyl)-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione hydrochloride; cytokines level reduced; tumor necrosis factor inhibitors; nontoxic; anticarcinogenic agents; antitumor agents (solid/blood-borne); cardiovascular disorders; osteoporosis; antiinflammatory agents; autoimmune diseases |
| 08/18/2009 | US7576089 CCR2 or CCR5 receptor antagonists; atherosclerosis, restenosis, lupus, organ transplant rejection and rheumatoid arthritis, cancer, multiple sclerosis, HIV infection; e.g. N-(2-((3S)-3-[(4-Hydroxy-4-phenylcyclohexyl)amino]pyrrolidin-1-yl)-2-oxoethyl)-3-(trifluoromethyl)benzamide |
| 08/18/2009 | US7576087 3-(Phenylsulfonyl)-7-piperazin-1-yl-1H-pyrazolo[4,3-b]pyridine; 5-HT receptor subtype 5HT6; selective serotonin receptor antagonist; cognition actiators; alzheimer's disease; attention deficit disorder; antidepressant; antiepileptic agent; anxiolytic agents; obsessive compulsive disorder; Parkinson's |
| 08/18/2009 | US7576086 N1-benzyl-N4-(phenylpropane-2-yl-3-ol)piperazine; triple action on hydroxytryptamine (5-HT), noradrenalin (NA)and dopamine(DA); on brain synapses; cytochrome P-450 monooxygenase enzyme system antagonists; enzyme inhibitors; side effect reduction |
| 08/18/2009 | US7576085 Imidazo[1,2-a]pyrazine compounds; cancers |
| 08/18/2009 | US7576082 rac-6-Chloro-3-(3-chloro-benzyl)-3-(1-methyl-1H-pyrazol-4-yl)-1,3-dihydro-indol-2-one; murine double minute (MDM2 ) oncogene inhibitor; feedback control loop of p53 mutant cells; inhibit the interaction between p53 and MDM2 proteins |
| 08/18/2009 | US7576079 Viral polymerase inhibitors |
| 08/18/2009 | US7576076 1-Methyl,2,6-dioxo,4-(4-(ethyloxycarbony)piperazin-1-yl-),5-(3-trifluoromethylphenyl)methyl-)-1,2,3,6-tetrahydropyrimidine; antagonist, antagonism; psychoses; antidepressants; schizophrenia; psychological disorders; Alzheimer's disease; neurodegenerative diseases;drug abuse, drug dependence (cocaine) |
| 08/18/2009 | US7576074 Receptor-type kinase modulators and methods of use |
| 08/18/2009 | US7576072 Heterocyclic inhibitors of MEK and methods of use thereof |
| 08/18/2009 | CA2577233C Pharmaceutical composition containing angiotensin ii antagonist |
| 08/18/2009 | CA2549479C Substituted arylpyrazoles as parasiticidal agents |
| 08/18/2009 | CA2393568C Diarylmethylpiperazines |
| 08/18/2009 | CA2239282C Fused isoindolones as inhibitors of protein kinase c |
| 08/18/2009 | CA2174526C Pseudodipeptide product possessing an imidazole group and the therapeutic, cosmetological and agri-food applications of the said product |
| 08/13/2009 | WO2009099080A1 Novel phenylpyrrole derivative |
| 08/13/2009 | WO2009098257A1 Composition for dyeing keratin fibres comprising at least one cationic diamino-n,n-dihydropyrazolone derivative |
| 08/13/2009 | WO2009098061A1 Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production |
| 08/13/2009 | WO2009098051A1 Aryl sulfonamides as effective analgesics |
| 08/13/2009 | WO2009097992A1 Insecticidal arylpyrrolines |
| 08/13/2009 | WO2009097972A1 Sf5 derivatives as par1 inhibitors, production thereof, and use as medicaments |
| 08/13/2009 | WO2009097695A1 Arylmethylidene heterocycles as novel analgesics |
| 08/13/2009 | WO2009097682A1 Anti-influenza compounds |
| 08/13/2009 | WO2009074575A3 Organic compounds |
| 08/13/2009 | WO2009045535A3 Fluorine-18 derivative of dasatinib and uses thereof |
| 08/13/2009 | WO2009030224A3 Novel quinazoline compounds and the use thereof for treating cancerous diseases |
| 08/13/2009 | US20090203906 4-[((4-carboxybutyl){2-[2-({4-[2-(4-hydroxyphenyl)ethyl]benzyl}oxy)phenyl]-ethyl}amino)methyl]benzoic acid, which stimulate soluble guanylate cyclase via a novel mechanism of action, used for the treatment of cardiovascular disorders and fibrotic disorders |
| 08/13/2009 | US20090203762 Methods for the production of biliverdin |
| 08/13/2009 | US20090203745 Heterocyclic compounds for the inhibition of integrins and use thereof |
| 08/13/2009 | US20090203714 Furo[3,2-B]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors |
| 08/13/2009 | US20090203708 Novel substituted-1-h-quinazoline-2,4-dione derivatives, preparation method thereof and pharmaceutical composition containing the same |
| 08/13/2009 | US20090203704 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative |
| 08/13/2009 | US20090203696 Aryl- and Heteroaryl-Ethyl-Acylguanidine Derivatives, Their Preparation and Their Application in Therapeutics |
| 08/13/2009 | US20090203690 5-substituted indazoles as kinase inhibitors |
| 08/13/2009 | US20090203683 Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them |
| 08/13/2009 | US20090203674 Pyrimidine compound and pests controlling composition containing the same |
| 08/13/2009 | US20090202638 Bmp gene and fusion protein |
| 08/13/2009 | US20090202573 Polymeric conjugates containing positively-charged moieties |
| 08/13/2009 | US20090202483 Hepatitis C Virus Inhibitors |
| 08/13/2009 | US20090202478 inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV); useful in establishing or determining the binding site of other antiviral compounds, for example, by competitive inhibition; used to treat or prevent viral contamination of materials |
| 08/13/2009 | CA2715143A1 Novel phenylpyrrole derivative |
| 08/13/2009 | CA2714966A1 Arylmethylidene heterocycles as novel analgesics |
| 08/13/2009 | CA2714181A1 Ampk modulators |
| 08/13/2009 | CA2714033A1 Insecticidal arylpyrrolines |
| 08/13/2009 | CA2713848A1 Anti-influenza compounds |
| 08/13/2009 | CA2712582A1 Aryl sulfonamides as effective analgesics |
| 08/13/2009 | CA2711582A1 Spirocyclic heterocycles, medicaments containing said compounds, use thereof and processes for the preparation thereof |
| 08/12/2009 | EP2088147A1 Dibenzo-condensed azepine, diazepine, oxazepine and thiazepine derivatives as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| 08/12/2009 | EP2088142A2 Compounds and Processes |
| 08/12/2009 | EP2086983A2 Fused ring compounds for inflammation and immune-related uses |
| 08/12/2009 | EP2086965A1 Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |